- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Debra Patt Acknowledges Progress Made Against Cancer
One of the important findings from the American Society of Clinical Oncology’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
One of the important findings from the American Society of Clinical Oncology (ASCO)’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
Transcript (slightly modified)
What were some of the key findings from ASCO’s annual report on the state of cancer care in the United States?
Well, I think one of the most important things that we recognize today is that while we’re seeing more cancer, cancer mortality continues to go down. So one of the findings in the report was that cancer mortality, in fact, has gone down by 1.5% per year for the last decade. I think that’s representative of progress: progress in screening and early detection, progress in more effective immediate therapies, progress in long-term therapies, and even in patients with incurable illness that they live longer. Those are great successes.
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
